During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes can cause gastroparesis due to its effects on the nervous system.
This report contains market size and forecasts of Gastroparesis Treatment Products in Global, including the following market information:
Global Gastroparesis Treatment Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gastroparesis Treatment Products market was valued at 5822.8 million in 2021 and is projected to reach US$ 7677.4 million by 2028, at a CAGR of 4.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastroparesis Treatment Products include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm and Ani Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastroparesis Treatment Products companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroparesis Treatment Products Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gastroparesis Treatment Products Market Segment Percentages, by Type, 2021 (%)
Drugs
Surgical Treatment Products
Global Gastroparesis Treatment Products Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gastroparesis Treatment Products Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Global Gastroparesis Treatment Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gastroparesis Treatment Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroparesis Treatment Products revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gastroparesis Treatment Products revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Medtronic
Boston Scientific